Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
November 21, 2023
Multicentric development and evaluation of [<sup>18</sup>F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy
François Lucia, Thomas Louis, François Cousin, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 9, 2023
Multicentric development and evaluation of <sup>18</sup>F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer
François Lucia, Vincent Bourbonne, Clémence Pleyers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 15, 2026
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial
Hugo Corda, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
European Urology Oncology
|
June 11, 2026
Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer
Quentin Josset, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
Clinical and Translational Radiation Oncology
|
March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Maximilien Rogé, Yoann Pointreau, Paul Sargos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 21, 2026
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study
Ewen Anger, Stephane Supiot, Quentin Josset, et al.
European Urology Oncology
|
February 7, 2025
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series
Ludwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 27, 2021
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ
Celine Bourgier, Didier Cowen, Florence Castan, et al.
European Urology Oncology
|
April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
Nicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 2, 2025
Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial
Celine Bourgier, Caroline Mollevi, Didier Cowen, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
European Journal of Nuclear Medicine and Molecular Imaging
|
November 21, 2023
Multicentric development and evaluation of [<sup>18</sup>F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy
François Lucia, Thomas Louis, François Cousin, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 9, 2023
Multicentric development and evaluation of <sup>18</sup>F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer
François Lucia, Vincent Bourbonne, Clémence Pleyers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 15, 2026
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial
Hugo Corda, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
European Urology Oncology
|
June 11, 2026
Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer
Quentin Josset, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
Clinical and Translational Radiation Oncology
|
March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Maximilien Rogé, Yoann Pointreau, Paul Sargos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 21, 2026
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study
Ewen Anger, Stephane Supiot, Quentin Josset, et al.
European Urology Oncology
|
February 7, 2025
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series
Ludwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 27, 2021
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ
Celine Bourgier, Didier Cowen, Florence Castan, et al.
European Urology Oncology
|
April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
Nicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 2, 2025
Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial
Celine Bourgier, Caroline Mollevi, Didier Cowen, et al.
Page
of 15